A phase III clinical trial comparing infusional 5-fluorouracil(5-FU), leucovorin, and oxaliplatin (mFOLFOX6). Every two weeks with bevacizumab to the same regimen without bevacizumab for the treatment of patients with resected stages II and III carcinoma.